Abstract: Imaging protein kinase expression with radiolabeled small molecule inhibitors has been actively pursued to monitor the clinical potential of targeted therapeutics and treatments as well as to determine kinase receptor density changes related to disease progression. The goal of the present review is to provide an overview of the breadth of radiolabeled small molecules that have been synthesized to target intracellular protein kinases, not only for imaging in oncology, but also for other areas of interest, particularly the central nervous system. Considerable radiotracer development has focused on imaging receptor tyrosine kinases of growth factors, protein kinases A, B and C, and glycogen synthase kinase–3β. Design considerations, structural attributes and relevant biological results are summarized.
This is an open access article distributed under the
Creative Commons Attribution License which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Export to BibTeX
MDPI and ACS Style
Hicks, J.W.; VanBrocklin, H.F.; Wilson, A.A.; Houle, S.; Vasdev, N. Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT. Molecules 2010, 15, 8260-8278.
Hicks JW, VanBrocklin HF, Wilson AA, Houle S, Vasdev N. Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT. Molecules. 2010; 15(11):8260-8278.
Hicks, Justin W.; VanBrocklin, Henry F.; Wilson, Alan A.; Houle, Sylvain; Vasdev, Neil. 2010. "Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT." Molecules 15, no. 11: 8260-8278.